Indian Journal of Pharmacy and Pharmacology · Aug 3, 2026

Hessian-optimized ensembles and regional phenotyping: A precision pharmacology framework for type 2 diabetes risk stratification

By Jena S, Kabrawala S, Gujral IS et al.

Type 2 Diabetes Mellitus has evolved from a manageable chronic condition into a global health and economic crisis. Conventional diagnostic strategies, reliant on fasting plasma glucose and glycated hemoglobin, identify metabolic dysfunction only after significant pancreatic beta-cell damage has already occurred. This paper presents a fundamentally different approach: using predictive metabolic phenotyping to forecast disease trajectory years before clinical onset. We describe a transition from simple linear models to sophisticated ensemble methods (Hessian-optimized XGBoost) and symbolic Kolmogorov-Arnold Networks (KANs). By integrating multi-omic biological data and calibrating for regional phenotypic variations, our system achieved 93.3% accuracy across ten global cohorts. Importantly, we incorporate a 'Glass Box' ethical framework using SHapley Additive exPlanations (SHAP) to ensure that clinicians and patients can readily understand the decision-making process. This represents a paradigm shift from reactive to predictive pharmacology.

doi.org/10.18231/j.ijpp.91443.1785741935Open accessBiomarkers